509 related articles for article (PubMed ID: 18360284)
1. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
[TBL] [Abstract][Full Text] [Related]
2. Ovarian ependymomas of extra-axial type or central immunophenotypes.
Stolnicu S; Furtado A; Sanches A; Nicolae A; Preda O; Hincu M; Nogales FF
Hum Pathol; 2011 Mar; 42(3):403-8. PubMed ID: 21195452
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
4. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
5. March 2003: a 41 -year-old female with a solitary lesion in the liver.
Wiendl H; Feiden W; Scherieble H; Renz T; Dichgans J; Weller M
Brain Pathol; 2003 Jul; 13(3):421-3. PubMed ID: 12946033
[TBL] [Abstract][Full Text] [Related]
6. Ependymoma of the ovary. A case report with immunohistochemical, ultrastructural, and DNA cytometric findings, as well as histogenetic considerations.
Guerrieri C; Jarlsfelt I
Am J Surg Pathol; 1993 Jun; 17(6):623-32. PubMed ID: 8333561
[TBL] [Abstract][Full Text] [Related]
7. Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein.
Curran AE; White DK; Damm DD; Murrah VA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Feb; 91(2):194-9. PubMed ID: 11174597
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
9. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
12. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.
Rodriguez FJ; Scheithauer BW; Robbins PD; Burger PC; Hessler RB; Perry A; Abell-Aleff PC; Mierau GW
Acta Neuropathol; 2007 Mar; 113(3):313-24. PubMed ID: 17061076
[TBL] [Abstract][Full Text] [Related]
13. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
14. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma.
Miller K; Price JH; Dobbs SP; McClelland RH; Kennedy K; McCluggage WG
J Clin Pathol; 2008 May; 61(5):652-7. PubMed ID: 18006668
[TBL] [Abstract][Full Text] [Related]
16. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
Cathro HP; Stoler MH
Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
[TBL] [Abstract][Full Text] [Related]
17. Ovarian ependymoma. A case report.
Garcia-Barriola V; De Gómez MN; Suárez JA; Lara C; González JE; García-Tamayo J
Pathol Res Pract; 2000; 196(8):595-9. PubMed ID: 10982025
[TBL] [Abstract][Full Text] [Related]
18. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
DeLair D; Oliva E; Köbel M; Macias A; Gilks CB; Soslow RA
Am J Surg Pathol; 2011 Jan; 35(1):36-44. PubMed ID: 21164285
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
[TBL] [Abstract][Full Text] [Related]
20. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
Lee BH; Hecht JL; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]